BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10834606)

  • 1. The application of flow cytometry to histocompatibility testing.
    Horsburgh T; Martin S; Robson AJ
    Transpl Immunol; 2000 Mar; 8(1):3-15. PubMed ID: 10834606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Standardization and automation of HLA B27 typing by flow cytometry: validation and comparison with microlymphocytotoxicity].
    Monneret G; Seffert O; Debard AL; Gutowski MC; Couprie N; Larbre JP; Tebib J; Bienvenu J
    Ann Biol Clin (Paris); 2000; 58(4):461-6. PubMed ID: 10932047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-B27 typing: evaluation of an allele-specific PCR melting assay and two flow cytometric antigen assays.
    Seipp MT; Erali M; Wies RL; Wittwer C
    Cytometry B Clin Cytom; 2005 Jan; 63(1):10-5. PubMed ID: 15624199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Routine HLA-B27 typing by flow cytometry: differentiation of the products of HLA-B*2702, B*2705 and B*2708.
    Coates E; Darke C
    Eur J Immunogenet; 1998 Feb; 25(1):29-37. PubMed ID: 9587742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of flow cytometry for HLA B27 phenotyping: study of a HLA B7/HLA B27 double marker technique].
    Ulrich G
    Allerg Immunol (Paris); 1997 Jan; 29(1):11-4. PubMed ID: 9213414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA typing of HLA-B27 by polymerase chain reaction.
    Lucotte G; Burckel A
    Mol Cell Probes; 1997 Aug; 11(4):313-5. PubMed ID: 9281420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term stabilized blood samples as controls for flow cytometric HLA-B27 screening: a feasibility study.
    Levering WH; Wind H; Granger V; Sintnicolaas K; Hooijkaas H; Reilly JT; Gratama JW; Barnett D
    Cytometry B Clin Cytom; 2008 May; 74(3):169-81. PubMed ID: 18200592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical cytometry and progress in HLA antibody detection.
    Bray RA; Tarsitani C; Gebel HM; Lee JH
    Methods Cell Biol; 2011; 103():285-310. PubMed ID: 21722808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimisation of HLA-B27 testing by association of flow cytometry and DNA typing.
    Bonnaud G; Aupetit C; Preux PM; Cogné M; Drouet M
    Clin Rheumatol; 1999; 18(1):23-7. PubMed ID: 10088944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular rejection post heart transplantation is associated with positive flow cytometric cross-matching.
    McCarthy JF; Cook DJ; Massad MG; Sano Y; O'Malley KJ; Ratliff NR; Stewart RW; Smedira NG; Starling RC; Young JB; McCarthy PM
    Eur J Cardiothorac Surg; 1998 Aug; 14(2):197-200. PubMed ID: 9755007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pronase-free B-cell flow-cytometry crossmatch.
    Hajeer AH; Saleh S; Sutton P; Shubaili A; Anazi H
    Saudi J Kidney Dis Transpl; 2009 Jul; 20(4):662-5. PubMed ID: 19587513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. External quality assessment of flow cytometric HLA-B27 typing.
    Levering WH; van den Beemd R; te Marvelde JG; van Beers WA; Hooijkaas H; Sintnicolaas K; Gratama JW
    Cytometry; 2000 Apr; 42(2):95-105. PubMed ID: 10797446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pronase independent flow cytometry crossmatching of rituximab treated patients.
    Alheim M; Wennberg L; Wikström AC
    Hum Immunol; 2018 Feb; 79(2):132-135. PubMed ID: 29157993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue typing for hematopoietic cell transplantation: newer techniques and newer antigens for which cross-matching is helpful.
    Iannone R; Davies SM
    Pediatr Transplant; 2005 Dec; 9 Suppl 7():76-80. PubMed ID: 16305621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human leukocyte antigen-B27 typing by flow cytometry: Comparison of three CE-IVD methods.
    Waeckel L; Kennel A; Berger AE; Lambert C
    Cytometry B Clin Cytom; 2023 Nov; 104(6):460-467. PubMed ID: 36448700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometry in human leukocyte antigen testing.
    Bray RA
    Semin Hematol; 2001 Apr; 38(2):194-200. PubMed ID: 11309700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved flow cytometry based cytotoxicity and binding assay for clinical antibody HLA crossmatching.
    Alheim M; Paul PK; Hauzenberger DM; Wikström AC
    Hum Immunol; 2015 Nov; 76(11):849-57. PubMed ID: 26429307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of four monoclonal antibodies against HLA-B27 for their reliability in HLA-B27 typing with flow cytometry (FC): comparison with the classic microlymphocytotoxic test (MLCT).
    Neumüller J; Schwartz DW; Dauber E; Mayr WR
    Cytometry; 1996 Sep; 26(3):209-15. PubMed ID: 8889393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A critical analysis of quantitating flow cytometry: the role of the crossmatch in 2014.
    Rosenberg JC; Eisenbrey AB; Jackowski M; Levis D; Peiter C; Putnam K; Tanner K; Ho CS
    Clin Transpl; 2013; ():423-32. PubMed ID: 25095538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the sensitized patient.
    Kerman RH
    Heart Fail Clin; 2007 Jan; 3(1):1-9. PubMed ID: 17545004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.